Pharmacology In Drug Discovery And Development ((link)) Jun 2026

The future of pharmacology is personalized. Genetic variants in CYP2C19 (affecting clopidogrel activation) or HLA-B*5701 (abacavir hypersensitivity) are now pre-screened. Regulatory agencies now encourage or mandate pharmacogenomic labeling. Discovery teams are designing "companion diagnostics" alongside drugs to identify responders.

If you are interested, I can provide more details on specific used in pre-clinical trials or delve deeper into QSP case studies for specific diseases like diabetes [5.5]. pharmacology in drug discovery and development

Pharmacology in Drug Discovery and Development: Driving Molecules to Medicines The future of pharmacology is personalized